77.79, 29.26; ESIMS: m/z 125 [M + H]+; Anal. Calcd for
C7H8O2: C, 67.74; H, 6.45. Found: C, 67.65; H, 6.52.
1H), 6.05 (ddd, J = 1.7, 1.7, 9.9 Hz, 1H), 5.88–5.74 (m, 2H),
5.36 (dd, J = 5.2, 7.2 Hz, 1H), 5.30 (dd, J = 3.5, 7.2 Hz, 1H),
5.17 (dd, J = 3.5, 7.0 Hz,1H), 4.96 (m, 1H) 4.90 (dq, J = 6.4,
6.4 Hz, 1H), 2.45 (m, 2H), 2.11 (s, 3H, CH3), 2.07 (s, 3H, CH3),
2.06 (s, 3H, CH3), 2.03 (s, 3H, CH3), 1.17 (d, J = 6.4 Hz, 3H,
CH3). 13C NMR (75.468 MHz, CDCl3): δ 170.03, 169.87,
169.72, 169.50, 163.57, 144.51, 133.07, 125.53, 121.64, 75.95,
71.91, 71.51, 70.40, 67.50, 29.46, 21.05, 20.90, 20.84, 20.50,
15.89; HRMS for C20H26O10+Na: calcd 449.1423; found:
449.1434.
(R)-6-((R,E)-3-((4S,5R)-5-((S)-1-(tert-Butyldimethylsilyloxy)
ethyl)-2,2-dimethyl-1,3-dioxolan-4-yl)-3-hydroxyprop-1-enyl)-
5,6-dihydro-2H-pyran-2-one (30)
A flame-dried round-bottomed flask was charged with alkene 6
(0.072 g, 0.230 mmol) and vinyl lactone
7 (0.057 g,
0.460 mmol) in CH2Cl2 (30 mL) and was added Grubb’s catalyst
(2nd generation, 0.19 g, 0.230 mmol) as a solid. The reaction
mixture was refluxed for 5 h to complete the reaction (by TLC)
and brought it to room temperature. The mixture was concen-
trated in vacuo and the residue, was purified by silica gel chrom-
atography using petroleum ether–EtOAc (9 : 1) to give 30
(0.081 g, 86% yield). [α]2D0 = + 10.1 (c 0.4, CHCl3); IR (KBr)
Acknowledgements
The
authors
express
their
grateful
thanks
to
Dr. S. Chandrasekhar, Scientist-G, Organic Chemistry Division-
I, Indian Institute of Chemical Technology, Hyderabad, India for
the scientific support. Also thankful to Prof. C.D. Reddy, Depart-
ment of Chemistry, Sri Venkateswara University, Tirupati for his
helpful discussions and the Council of Scientific and Industrial
Research Project (01/2347/09/EMR-II) CSIR, New Delhi, India
for providing financial support.
2925, 1739, 1374, 1023, 974 cm−1 1H NMR (400 MHz,
;
CDCl3): δ 6.87 (dt, J = 8.6, 3.8 Hz, 1H), 6.04 (d, J = 9.8 Hz,
1H), 5.87 (d, J = 15.5 Hz, 1H), 5.83 (d, J = 15.3 Hz, 1H), 4.95
(brs, 1H), 4.20 (brd, J = 2.3 Hz, 1H), 3.98 (dd, J = 6.3, 3.0 Hz,
1H), 3.86 (t, J = 6.8 Hz, 1H), 3.79 (dq, J = 12.2, 6.0 Hz, 1H),
2.54–2.34 (m, 2H), 1.41 (s, 3H), 1.36 (s, 3H), 1.21 (d, J = 5.9
Hz, 3H), 0.87 (s, 9H), 0.07 (s, 3H), 0.05 (s, 3H); 13C NMR
(100 MHz, CDCl3): δ 163.76, 144.55, 131.42, 130.76, 121.63,
109.55, 81.61, 80.70, 77.06, 75.16, 70.53, 29.64, 27.66, 27.11,
25.86, 21.33, 17.98, −4.25, −4.39; HRMS for C21H36O6Si+Na:
calcd 435.2179; found: 435.2174.
References
1 A. Alemany, C. Marquez, C. Pascual, S. Valverde, M. Martínez-Ripoll,
J. Fayos and A. Perales, Tetrahedron Lett., 1979, 20, 3583.
2 J. A. Marco, M. Carda, J. Murga and E. Falomir, Tetrahedron, 2007, 63,
2929.
3 H. Kikuchi, K. Sasaki, J. Sekiya, Y. Maeda, A. Amagai, Y. Kubohara and
Y. Ohsima, Bioorg. Med. Chem., 2004, 12, 3203.
4 (a) V. K. Agrawal, J. Singh, K. C. Mishra, P. V. Khadikar and Y.
A. Jaliwala, ARKIVOC, 2006, ii, 162; (b) S. E. Hagen, J. M. Domagala,
C. Gajda, M. Lovdahl, B. D. Tait, E. Wise, T. Holler, D. Hupe,
C. Nouhan, A. Urumov, G. Zeikus, E. Zeikus, E. A. Lunney,
A. Pavlovsky, S. J. Gracheck, J. M. Saunders, S. VanderRoest and
J. Brodfuehrer, J. Med. Chem., 2001, 44, 2319; (c) S. E. Hagen,
J. V. N. Vara-Prasad and B. D. Tait, Adv. Med. Chem., 2000, 5, 159; (d) P.
A. Aristoff, Drugs Future, 1998, 23, 995; (e) K. R. Romines and R.
A. Chrusciel, Curr. Med. Chem., 1995, 2, 825.
5 (a) K. M. Chan, N. F. Rajab, M. H. A. Ishak, A. M. Ali, K. Yusoff, L.
B. Din and S. H. Inayat-Hussain, Chem.-Biol. Interact., 2006, 159, 129;
(b) S. H. Inayat-Hussain, B. O. Annuar, L. B. Din, A. M. Ali and
D. Ross, Toxicol. in Vitro, 2003, 17, 433; (c) S. H. Inayat-Hussain, B.
O. Annuar, L. B. Din and N. Taniguchi, Toxicol. Lett., 2002, 131, 153.
6 For further literature related to this important biological property, see, for
example: (a) Z. W. Huang, Chem. Biol., 2002, 9, 1059; (b) N. B. Blatt
and G. D. Glick, Bioorg. Med. Chem., 2001, 9, 1371.
Synthesis of (+)-anamarine (1)
To a stirred solution of 30 (0.016 g, 0.040 mmol) in a mixture of
MeOH–water (9 : 1, 2 mL) was added p-PTS (0.005 g,
0.020 mmol) at room temperature, and the reaction mixture was
refluxed for 12 h. After completion of the reaction (TLC),
NaHCO3 (0.150 g) was added and the mixture was stirred for
5 min. It was filtered through a short pad of Celite and was
washed with CHCl3 (15 mL). The residue obtained after evapor-
ation of the solvent was purified by a short-path silica gel
column chromatography using EtOAc–MeOH (4 : 1) as eluent to
furnish the tetrol, which was used as such in the next step
without characterization.
To a precooled (0 °C) solution of the tetrol obtained above in
CH2Cl2 (1 mL) were added DMAP (0.001 g, 0.007 mmol) and
Et3N (0.055 mL, 0.400 mmol) followed by Ac2O (0.032 mL,
0.033 mmol) under argon atmosphere. The reaction mixture was
stirred at room temperature for 1 h. After completion of the reac-
tion (TLC), it was poured into cold water and extracted with
EtOAc (2 × 10 mL). The combined organic layers were washed
with brine (5 mL) and dried over Na2SO4. Evaporation of
solvent followed by column chromatography of the resultant
residue using petroleum ether–EtOAc (1 : 1) as eluent furnished
(+)-anamarine 1 (0.010 g) in 80% yield as a white solid: mp =
107–109 °C; [α]2D0 = + 17.1 (c 0.3, CHCl3); lit.1 for natural ana-
marine, mp 110–112 °C; [α]D = +14.5 (c 0.06; CHCl3); lit.1 for
natural anamarine, [α]D = + 28.2 (c 0.52; CHCl3), value later
revised to + 18.8; lit.8 for synthetic (+)-anamarine, [α]D = +15.9
(c 0.8; CHCl3); IR (KBr) 2925, 1739, 1374, 1023, 974 cm−1; 1H
NMR (300 MHz, CDCl3): δ 6.88 (ddd, J = 3.5, 5.2, 9.9 Hz,
7 See, for example: (a) F. Koizumi, H. Ishiguro, K. Ando, H. Kondo,
M. Yoshida, Y. Matsuda and S. Nakanishi, J. Antibiot., 2003, 56, 603;
(b) A. Richetti, A. Cavallaro, T. Ainis and V. Fimiani, Immunopharmacol.
Immunotoxicol., 2003, 25, 441; (c) A. K. Larsen, A. E. Escargueil and
A. Skladanowski, Pharmacol. Ther., 2003, 99, 167; (d) D. S. Lewy, C.-
M. Gauss, D. R. Soenen and D. L. Boger, Curr. Med. Chem., 2002, 9,
2005; (e) G. E. Raoelison, C. Terreaux, E. F. Queiroz, F. Zsila,
M. Simonyi, S. Antus, A. Randriantsoa and K. Hostettmann, Helv. Chim.
Acta, 2001, 84, 3470; (f) H. Nagashima, K. Nakamura and T. Goto,
Biochem. Biophys. Res. Commun., 2001, 287, 829; (g) S. S. Stampwala,
R. H. Bunge, T. R. Hurley, N. E. Willmer, A. J. Brankiewicz, C.
E. Steinman, T. A. Smitka and J. C. French, J. Antibiot., 1983, 36, 1601.
8 (a) K. Lorenz and F. W. Lichtenthaler, Tetrahedron Lett., 1987, 28, 6437;
(b) K. R. Prasd and K. Penchalaiah, J. Org. Chem., 2011, 76, 6889.
9 S. Diaz-Oltra, J. Murga, E. Falomir, M. Carda and J. A. Marco, Tetrahe-
dron, 2004, 60, 2979.
10 D. Gao and G. A. O’Doherty, J. Org. Chem., 2005, 70, 9932.
11 G. Sabitha, C. N. Reddy, P. Gopal and J. S. Yadav, Tetrahedron Lett.,
2010, 51, 5736.
12 (a) A. B. Krishna, M. V. N. Reddy, P. V. Rao, M. A. Kumar, B.
S. Kumar, S. K. Nayak and C. S. Reddy, Eur. J. Med. Chem., 2011, 46,
2654 | Org. Biomol. Chem., 2012, 10, 2647–2655
This journal is © The Royal Society of Chemistry 2012